CDK12 and neoplasm: Nonetheless, the presence of mutations in the DNA damage repair (DDR) genes (e.g., BRCA1, BRCA2, CDK12, ATM) has been associated with an increased number of DNA errors and high tumor neoantigen expression, and thus could be predictive of response to immune checkpoint monoclonal antibodies [59].